0 Comments
0 Shares
476 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
HER2 Positive Breast Cancer Treatment Market: Advancing Precision Oncology Through Targeted TherapiesMarket Introduction HER2 positive breast cancer represents a biologically distinct and clinically aggressive subtype of breast cancer characterized by the overexpression of the human epidermal growth factor receptor 2 (HER2) protein. This overexpression accelerates tumor growth and increases the likelihood of disease progression if left untreated. Over the past two decades, advancements in...0 Comments 0 Shares 1K Views 0 Reviews
-
Immuno Oncology Assays Market Overview: Key Drivers and ChallengesImmuno Oncology Assays Market Summary: According to the latest report published by Data Bridge Market Research, the Immuno Oncology Assays Market CAGR Value The global immuno oncology assays market size was valued at USD 6.80 billion in 2025 and is expected to reach USD 16.45 billion by 2033, at a CAGR of 11.68% during the forecast period DBMR...0 Comments 0 Shares 431 Views 0 Reviews
-
Immuno Oncology Assays Market: Insights and Competitive AnalysisExecutive Summary Immuno Oncology Assays Market Size and Share Across Top Segments CAGR Value The global immuno oncology assays market size was valued at USD 6.80 billion in 2025 and is expected to reach USD 16.45 billion by 2033, at a CAGR of 11.68% during the forecast period To better structure this Immuno Oncology Assays report, a nice blend of...0 Comments 0 Shares 908 Views 0 Reviews
-
Immuno-Oncology and ADCs Market Industry Analysis Report by Product, Application & End UserAccording to the latest report published by Data Bridge Market Research, the Immuno-Oncology and ADCs Market The global immuno-oncology & ADCs market size was valued at USD 11.88 billion in 2024 and is expected to reach USD 34.12 billion by 2032, at a CAGR of 14.10% during the forecast period Immuno-Oncology and ADCs Market report endows with the data and statistics on the current...0 Comments 0 Shares 147 Views 0 Reviews
-
Long-Acting Injectable Oncology Drug Market Intelligence Report with Demand AnalysisAccording to the latest report published by Data Bridge Market Research, the Long-Acting Injectable Oncology Drug Market The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period Winning Long-Acting Injectable Oncology Drug Market research...0 Comments 0 Shares 123 Views 0 Reviews
-
Oncology Biosimilar Monoclonal Antibodies market Research Report by End User & Industry Vertical"Oncology Biosimilar Monoclonal Antibodies Market Summary: According to the latest report published by Data Bridge Market Research, the Oncology Biosimilar Monoclonal Antibodies Market The global oncology biosimilar monoclonal antibodies market size was valued at USD 1.38 billion in 2025 and is expected to reach USD 2.79 billion by 2033, at a CAGR of 9.10% during the forecast period A...0 Comments 0 Shares 355 Views 0 Reviews
-
Post-CDK4/6 Treatment Line Oncology Drugs Market Industry Assessment: Demand Trends and Outlook 2025–2033According to the latest report published by Data Bridge Market Research, the Post-CDK4/6 Treatment Line Oncology Drugs Market The global post-CDK4/6 treatment line oncology drugs market size was valued at USD 3.53 billion in 2025 and is expected to reach USD 10.06 billion by 2033, at a CAGR of 14.00% during the forecast period The reliable Post-CDK4/6...0 Comments 0 Shares 89 Views 0 Reviews
-
(R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....0 Comments 0 Shares 478 Views 0 Reviews
-
Advancements in Oncology Treatments Accelerate Chemotherapy Drug Market Growth"Regional Overview of Executive Summary Chemotherapy Drug Market by Size and Share CAGR Value Data Bridge Market Research analyses that the chemotherapy drug market which was USD 47,028.67 million in 2022, would rocket up to USD 97,914.53 million by 2030, and is expected to undergo a CAGR of 9.6% during the forecast period. The market report also contains the drivers and restraints...0 Comments 0 Shares 696 Views 0 Reviews
-
Anastrozole Tablets Market Size, Share, Oncology Drug Trends and Forecast Report 2026–2033" Anastrozole Tablets Market Summary: According to the latest report published by Data Bridge Market Research, the Anastrozole Tablets Market share The global anastrozole tablets market size was valued at USD 410.71 million in 2025 and is expected to reach USD 512.25 million by 2033, at a CAGR of 2.80% during the forecast period Global market research analysis report gives...0 Comments 0 Shares 389 Views 0 Reviews
-
Anthracycline-Based Oncology Drug Class Market Advances with Continued Role in Chemotherapy Regimens and Expanding Cancer Treatment ApplicationsAccording to the latest report published by Data Bridge Market Research, the Anthracycline-Based Oncology Drug Class Market The global anthracycline-based oncology drug class market size was valued at USD 5.40 billion in 2025 and is expected to reach USD 7.33 billion by 2033, at a CAGR of3.90% during the forecast period A talented team works strictly with their potential capabilities...0 Comments 0 Shares 59 Views 0 Reviews
-
Adrenal Cancer Diagnostics Market Size, Share and Trends Forecast to 2030According to the latest report published by Data Bridge Market Research, the Adrenal Cancer Diagnostics Market Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as...0 Comments 0 Shares 364 Views 0 Reviews
-
Advancements in Biopharmaceuticals Accelerate the Global EPO Drugs MarketGlobal Demand Outlook for Executive Summary Erythropoietin (EPO) Drugs Market Size and Share CAGR Value Global Erythropoietin (EPO) Drugs Market report is a highly visual business report where the key market research findings have been organized, analyzed, and summarized neatly. This report can be communicated more effectively with a team, stakeholders, and customers. With devotion,...0 Comments 0 Shares 954 Views 0 Reviews
-
Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...0 Comments 0 Shares 14K Views 0 Reviews
-
Asia-Pacific Radiotherapy Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Asia-Pacific Radiotherapy Market The Asia-Pacific radiotherapy market size was valued at USD 1.06 billion in 2024 and is expected to reach USD 2.40 billion by 2032, at a CAGR of 11.2% during the forecast period This world-wide Asia-Pacific Radiotherapy Market report is...0 Comments 0 Shares 30 Views 0 Reviews
-
Biotech Collaborations Increasing Competition in Clinical Trials IndustryThe clinical trials market is witnessing strong momentum as pharmaceutical and biotechnology companies continue to increase investments in research and development to accelerate the discovery of advanced therapies. The global clinical trials market size was estimated at USD 89.0 billion in 2025 and is projected to reach USD 158.4 billion by 2033, growing at a CAGR of 7.7% from 2026 to 2033. The...0 Comments 0 Shares 538 Views 0 Reviews
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. With the effectual use of technology, innovative applications and expertise, Blood Cancer Market...0 Comments 0 Shares 299 Views 0 Reviews
-
Breast Cancer Drugs Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Comments 0 Shares 204 Views 0 Reviews
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Comments 0 Shares 1K Views 0 Reviews
More Results
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek